We are a pharmaceutical company discovering and developing novel drug candidates to treat inflammation and blood cancers. Our primary focus is anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1, or SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. Aquinox has a broad intellectual property portfolio and pipeline of preclinical drug candidates that activate SHIP1.
View Top Employees from Aquinox Pharmaceuticals, Inc.Website | http://www.aqxpharma.com |
Ticker | AQXP |
Revenue | $25 million |
Funding | $46.2 million |
Employees | 36 (9 on RocketReach) |
Founded | 2006 |
Address | 887 GREAT NORTHERN WAY Ste. 450, Vancouver, British Columbia V5T 4T5, CA |
Phone | (604) 629-9223 |
Fax | (778) 331-4486 |
Technologies |
HTML,
OpenResty,
DNS Made Easy
+2 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Drug Manufacturing & Research, Science and Engineering, Healthcare, Health Care, Therapeutics |
Web Rank | 9 Million |
Keywords | Aquinox Pharma, Aquinox Pharmaceuticals, Inc., Aquinox, Aquinox Pharmaceuticals, Aquinox 10k |
Competitors | Catabasis Pharmaceuticals, Inc., Chlorion Pharma, G1 Therapeutics, Inc., Kalypsys, Portola Pharmaceuticals |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 42 Companies, NAICS Code 3254 Companies, NAICS Code 424 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 4242 Companies, NAICS Code 42421 Companies, NAICS Code 32 Companies |
Looking for a particular Aquinox Pharmaceuticals, Inc. employee's phone or email?
The Aquinox Pharmaceuticals, Inc. annual revenue was $25 million in 2023.
9 people are employed at Aquinox Pharmaceuticals, Inc..
Aquinox Pharmaceuticals, Inc. is based in Vancouver, British Columbia.
The NAICS codes for Aquinox Pharmaceuticals, Inc. are [42, 3254, 424, 32541, 325, 4242, 42421, 32].
The SIC codes for Aquinox Pharmaceuticals, Inc. are [28, 283].